• Alpha Cognition appointed Caren Deardorf to its board of directors, effective Nov. 9, 2026.
• Deardorf is chief business and strategy officer at Neutrolis, overseeing commercial and corporate strategy.
• She previously served as chief commercial and strategy officer at Editas Medicine and spent 20 years at Biogen.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Cognition Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261109133062) on November 09, 2026, and is solely responsible for the information contained therein.